Premal Patel's most recent trade in eFFECTOR Therapeutics Inc was a trade of 150,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 20, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| eFFECTOR Therapeutics Inc | Premal Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Premal Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 424,911 | 424,911 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Premal Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 62,593 | 62,593 | - | - | Earn-out Right |